The core of Agenus’ operations revolves all-around harnessing the strength of the immune program to focus on and take care of tough-to-take care of cancers and infections. The business’s product candidates are intended to teach and activate immune responses by precisely targeting most cancers cells, thus offering prospective new avenues during